Form D · Biotechnology

SOFIE BIOSCIENCES, INC.

Culver City, CA · CIK 0001590830

Offering snapshot reported Jul 29, 2019 · SEC filing

Reported sold
$950K
Offering amount: $950K
Investors reported
14
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 12, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 29, 2019Initial$950,000No comparison14SEC filing
Jun 6, 2017InitialYet to sellNo comparison0SEC filing
Jun 13, 2016Initial$3,700,000No comparison9SEC filing
Nov 4, 2013Initial$5,000,004No comparison12SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-345208

Source: Form D, filed Jul 29, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Stan Berman Executive
Joel Cohen Executive
Philipp Czernin Executive
Johannes Czernin Director
Roy Doumani Director
James Heath Director
Ken Hermann, M.D. Director
K. Leonard Judson Director
Howard Maron Director
Carl W. Mc Kinzie Director
Melissa Moore, Ph.D Executive
Patrick E. Phelps Director, Executive
Michael E. Phelps Director
Ajit Singh Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
6160 Bristol Parkway Suite 200
Culver City, CA, 90230